English

This webpage discusses how the faith community continues to play an essential role in shaping the public’s knowledge, attitudes, beliefs and behaviors. Faith-based organizations (FBOs) have been key components in a comprehensive HIV prevention strategy for building awareness, mobilizing communities, and reducing HIV-related stigma. The role FBOs play in local communities puts them in a unique position to influence their congregation to get tested, seek care, and remain virally suppressed.

This webpage discusses HIV criminalization and how the criminalization of HIV transmission or exposure dates back to the early history of the HIV epidemic.

This webpage discusses the intersection between women and HIV. In 2021, 18% of the new HIV diagnoses in the United States and dependent areas were among women and 23% of all people living with HIV were women. In addition, Black women represent 54% of new HIV diagnoses among women.

This video from AIDSVu explains what the PrEP-to-need ratio is how it is implemented.

This guide assists navigators working with people diagnosed with or at risk for HIV. Navigators can play
a crucial role in helping people living with HIV (PLWH) because nowhere is the need to change behaviors
more important than in HIV infection. Changing risky behaviors can prevent transmission of the virus,
and people living with HIV have better outcomes when they are able to change from risky to healthier
behaviors. 

The National Health and Nutrition Examination Survey (NHANES) underestimates the true prevalence of hepatitis C virus (HCV) infection in the U.S. due to inadequate representation of certain populations. Two models were developed to provide more accurate estimates of HCV prevalence among U.S. adults from 2017 to 2020.

This webinar recording features updates on new hepatitis C prevalence estimates.

This fact sheet shares information regarding doxy PEP usage.

This technical information note provides guidance to TB programme managers and quantification and procurement officers. The note includes information about the child-friendly DR-TB formulations and guidance on how to quantify and plan an order.

This fact sheet provides basic information on the transmission, symptoms, testing, and treatment of TB.